Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN Trials.

Autor: Zahoor MA; Department of Medicine, Division of Gastroenterology & Hepatology, Toronto Center for Liver Disease, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada., Feld JB; Department of Medicine, Division of Gastroenterology & Hepatology, Toronto Center for Liver Disease, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada., Lin HS; Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Mosa AI; Department of Medicine, Division of Gastroenterology & Hepatology, Toronto Center for Liver Disease, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada., Salimzadeh L; Department of Medicine, Division of Gastroenterology & Hepatology, Toronto Center for Liver Disease, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada., Perrillo RP; Department of Medicine, Baylor Scott & White Medical Center, Dallas, Texas, USA., Chung RT; Masschusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Schwarz KB; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Janssen HLA; Department of Medicine, Division of Gastroenterology & Hepatology, Toronto Center for Liver Disease, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Department of Gastroenterology & Hepatology, Erasmus MC University Hospital Rotterdam, Rotterdam, The Netherlands., Gehring AJ; Department of Medicine, Division of Gastroenterology & Hepatology, Toronto Center for Liver Disease, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada., Feld JJ; Department of Medicine, Division of Gastroenterology & Hepatology, Toronto Center for Liver Disease, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2025 Jan 01; Vol. 81 (1), pp. 254-268. Date of Electronic Publication: 2024 Apr 17.

Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B.

Autor: Terrault NA; Gastrointestinal and Liver Diseases Division, Keck Medicine of University of Southern California, Los Angeles, California, USA., Lok AS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA., Wahed AS; Departments of Biostatistics, and Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Ghany MG; Liver Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA., Perrillo RP; Baylor University Medical Center, Dallas, Texas, USA., Fried MW; Division of Gastroenterology, University of North Carolina, Chapel Hill, North Carolina, USA., Wong DK; Toronto Centre for Liver Disease, University of Toronto, Toronto, Ontario, Canada., Khalili M; Department of Medicine, University of California San Francisco, San Francisco, California, USA., Lau DTY; Liver Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA., Sterling RK; Section of Hepatology, Virginia Commonwealth University, Richmond, Virginia, USA., Di Bisceglie AM; Department of Medicine, University of St. Louis, St. Louis, Missouri, USA., Lisker-Melman M; Washington University School of Medicine and John Cochran VA Medical Center, St. Louis, Missouri, USA., Cooper SL; San Francisco Center for Liver Disease, California Pacific Medical & Research Institute, San Francisco, California, USA., Chung RT; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Patel K; Toronto Centre for Liver Disease, University of Toronto, Toronto, Ontario, Canada., Roberts LR; Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA., Belle SH; Departments of Biostatistics, and Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Janssen HLA; Toronto Centre for Liver Disease, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: The American journal of gastroenterology [Am J Gastroenterol] 2023 Jul 01; Vol. 118 (7), pp. 1214-1225. Date of Electronic Publication: 2022 Dec 23.

Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection.

Autor: Feld JJ; Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: jordan.feld@uhn.ca., King WC; Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania., Ghany MG; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland., Chang KM; University of Pennsylvania Perelman School of Medicine and the Corporal Michael J. Crescenz VAMC, Philadelphia, Pennsylvania., Terrault N; University of Southern California, Los Angeles, California., Perrillo RP; Baylor Scott and White Medical Center, Dallas, Texas., Khalili M; University of California San Francisco, San Francisco, California., Hinerman AS; Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania., Janssen H; Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Ontario, Canada., Lok AS; University of Michigan, Ann Arbor, Michigan.

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2023 Jun; Vol. 21 (6), pp. 1503-1512.e4. Date of Electronic Publication: 2022 Jul 16.

Herbal hepatitis due to use of alternative medicines for Lyme disease.

Autor: Perrillo RP; Hepatology Division, Baylor University Medical Center and University of Texas Southwestern Medical Center, Dallas, Texas., Burton JR Jr; Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Westbrook LM; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Publikováno v: Proceedings (Baylor University. Medical Center) [Proc (Bayl Univ Med Cent)] 2021 Oct 19; Vol. 35 (1), pp. 104-105. Date of Electronic Publication: 2021 Oct 19 (Print Publication: 2022).

Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.

Autor: Brahmania M; Division of Gastroenterology, Toronto General Hospital, University Health Network, Toronto, Canada., Lombardero M; Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania., Hansen BE; Division of Gastroenterology, Toronto General Hospital, University Health Network, Toronto, Canada; IHPME, University of Toronto, Toronto, Canada., Terrault NA; Division of Gastroenterology, University of California-San Francisco, San Francisco, California., Lok AS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan., Perrillo RP; Division of Gastroenterology, Baylor University Medical Center, Dallas, Texas., Belle SH; Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania., Di Bisceglie AM; Division of Gastroenterology and Hepatology, Saint Louis University, St Louis, Missouri., Feld JJ; Division of Gastroenterology, Toronto General Hospital, University Health Network, Toronto, Canada., Lee WM; Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas., Fried MW; Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina., Janssen HLA; Division of Gastroenterology, Toronto General Hospital, University Health Network, Toronto, Canada. Electronic address: Harry.Janssen@uhn.ca.

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2019 Nov; Vol. 17 (12), pp. 2541-2551.e2. Date of Electronic Publication: 2019 Feb 08.